Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321

Mid-range Performer

Download real time

926.40 -1.60 (-0.17%)

30.05% Fall from 52W High

518.3K NSE+BSE Volume

NSE 03 Jun, 2025 3:31 PM (IST)

93,217.5

Market Cap

High in industry

0.7

Beta 1Year

Very Low volatility

US FDA Approval

Zydus Lifesciences gets US FDA approval for Rifaximin tablets with a market size of $2.6 bn See details

Zydus Lifesciences Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Zydus Lifesciences Ltd. from all sources in a single place.

Load latest

Is Cadila Healthcare Ltd. worth buying?

845 Votes:

Buy 82.13%

Sell 9.82%

Hold 8.05%

RESEARCH REPORTS

Accumulate SEE REPORTS >

Hold SEE REPORTS >